[{"AccountsReceivableNetCurrent_0_Q1_USD":2063100000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":336000000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":321500000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":468300000.0,"OtherLiabilitiesCurrent_0_Q1_USD":85000000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":73900000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":441200000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":170100000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":3236400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":2220700000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":1795100000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":2674500000.0,"TreasuryStockValue_0_Q1_USD":1073800000.0,"TreasuryStockShares_0_Q1_shares":5683562.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-28800000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":96400000.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q1_USD":-9900000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":715200000.0,"EarningsPerShareDiluted_1_Q1_USD":5.43,"DepreciationDepletionAndAmortization_1_Q1_USD":56100000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":771200000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":668600000.0,"MarketableSecuritiesCurrent_0_Q1_USD":1795200000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":1143200000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":155100000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":23500000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":714300000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":155100000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-82600000.0,"OtherInventoryNetOfReserves_0_Q1_USD":481400000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":-1400000.0,"MarketableSecuritiesRealizedGainLoss_1_Q1_USD":0.0,"LossContingencyAccrualAtCarryingValue_0_Q1_USD":117000000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":692200000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":210900000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q1_USD":55600000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-56800000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":31900000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":2039600000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":31900000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":2039600000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":590400000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":4469600000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":4478000000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":31900000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":108000000.0,"RestrictedCash_0_Q1_USD":12500000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-30200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":109800000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2944600000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":811400000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":226600000.0,"OtherOperatingIncomeExpenseNet_1_Q1_USD":40400000.0,"NetIncomeLoss_1_Q1_USD":624600000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":698000000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-443200000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":335600000.0,"LiabilitiesCurrent_0_Q1_USD":2055200000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":15757500000.0,"Liabilities_0_Q1_USD":3624500000.0,"InventoryNet_0_Q1_USD":1480900000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-70100000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":169000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":44000000.0,"CostsAndExpenses_1_Q1_USD":1128100000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":2208200000.0,"AssetsCurrent_0_Q1_USD":8644100000.0,"Assets_0_Q1_USD":15757500000.0,"AdditionalPaidInCapital_0_Q1_USD":5211400000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-9100000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":8004400000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":594400000.0,"StockholdersEquity_0_Q1_USD":12133000000.0,"OperatingIncomeLoss_1_Q1_USD":700100000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":817400000.0,"OtherAssetsNoncurrent_0_Q1_USD":161200000.0,"NonoperatingIncomeExpense_1_Q1_USD":-31500000.0,"EarningsPerShareBasic_1_Q1_USD":5.69,"AccountsPayableCurrentAndNoncurrent_0_Q1_USD":347800000.0,"AccountsAndNotesReceivableNet_0_Q1_USD":401800000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-25400000.0,"IncreaseDecreaseInInventories_1_Q1_USD":70800000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-85200000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.066,"AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_1_Q1_USD":73400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":115100000.0,"ShareBasedCompensation_1_Q1_USD":105800000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":367300000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":583900000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":30000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":320700000.0,"InterestExpense_1_Q1_USD":6100000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1828200000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200505"}]